Please login to the form below

Not currently logged in
Email:
Password:

osteoporosis

This page shows the latest osteoporosis news and features for those working in and with pharma, biotech and healthcare.

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB and Amgen have finally claimed European approval for their osteoporosis drug Evenity, which becomes the first new drug for the disease in the EU since 2010. ... showed impressive activity in reducing fracture rates and improving bone mineral density

Latest news

More from news
Approximately 11 fully matching, plus 192 partially matching documents found.

Latest Intelligence

  • The evolution of marketing – the Amgen way The evolution of marketing – the Amgen way

    There is tremendous opportunity – and a massive need – to bend the curve for serious illnesses, such as cancer, cardiovascular disease and osteoporosis, which affect tens of millions of people worldwide.

  • Case study: frACTure Case study: frACTure

    The campaign featured on- and off-line communications and activities that educated employees about osteoporosis and fractures. ... It showed how committed the company is to raising awareness of osteoporosis and fragility fractures.

  • Deal Watch September 2016 Deal Watch September 2016

    Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis.

  • Medical affairs - the time for change is now Medical affairs - the time for change is now

    FLIP aims at supporting the implementation of Fracture Liaison Services (FLS) for secondary fracture prevention in patients suffering from osteoporosis. ... FLS is a coordinated multidisciplinary approach to patient care. To date the FLIP programme has

  • Pharma deals in June 2015 Pharma deals in June 2015

    The device, which has been tested in the clinic for the delivery of parathyroid hormone in osteoporosis patients, can be programmed to release drug at precise times and on a

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics